Cellaïon SA is a Belgian biotechnology company developing life-saving advanced therapies to repair tissue and regenerate the liver; Cellaïon primarily targets potentially lethal diseases without medical solutions.
Located in the biotech valley of the Walloon Region in Belgium, we are a team of biotech entrepreneurs, physicians and highly talented scientists in the field of liver diseases and regenerative medicine and biotechnology.
Our lead product HepaStem® is in advanced clinical development (Phase IIB) and offers a therapeutic solution for severe and potentially lethal liver diseases, with the ambition to improve survival and provide an alternative to liver transplantation
HepaStem® is a signaling cell that acts as a transport cargo ship by delivering powerful immunomodulatory and anti-inflammatory signals to target tissues to restore immunological balance.
Our scientific and medical expertise is also supported by a strong regulatory organization.
The company masters in-house manufacturing, supply chain logistics and delivery.
The company has strong intellectual property covering our activities beyond 2040
